Abstract: The present invention relates to a pharmaceutical combination, the pharmaceutical combination comprising a glucokinase activator or a pharmaceutically acceptable salt thereof, an isotopic label thereof, a crystal form thereof, a hydrate, a solvate, a diastereomer or enantiomer, and a K-ATP channel blocker. The present invention further relates to a pharmaceutical composition, a fixed dose compound preparation, and a method for preparing the pharmaceutical composition and the fixed dose compound preparation as well as a use thereof.
Type:
Grant
Filed:
May 28, 2019
Date of Patent:
June 6, 2023
Assignee:
HUA MEDICINE (SHANGHAI) LIMITED
Inventors:
Li Chen, Yongguo Li, Gaosen Wang, Huisheng Gao